CureApp, Inc. is a company headquartered in Tokyo, Japan, that has successfully launched prescription digital therapeutics.
Subscribe to see CureApp, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
CureApp, Inc. is a digital health / medtech company headquartered in Japan. Xcout tracks 16 named people at CureApp, Inc., including 久納 裕治 (コーポレート統括取締役/CFO).
10 more named people on record for CureApp, Inc., with roles, board committees and tenure — see the full roster →
A few of CureApp, Inc.'s closest competitors — see the full list of competitors and alternatives →
ReSet Therapeutics, operating through PursueCare, provides FDA-authorized prescription digital therapeutics designed to aid patients undergoing outpatient treatment for substance use and opioid use disorders. The smartphone applications deliver interactive cognitive behavioral therapy, track triggers and cravings, and connect patients with their healthcare providers to support long-term recovery.
HelloBetter provides evidence-based digital mental health programs and online therapy solutions, including prescription-based digital health applications (DiGA).
Dawn Health is a digital health solutions provider that powers digital health products and global solutions for pharmaceutical companies across therapeutic areas like oncology.
Renalis LLC develops FDA-cleared prescription digital therapeutics designed to treat pelvic health disorders. Its flagship product, CeCe, is a mobile-enhanced digital therapeutic that provides behavioral therapy for overactive bladder in persons assigned female at birth.
CureGrail, LLC provides digital patient engagement solutions focused on diabetes care delivery. The company collaborates with patients and healthcare providers to utilize predictive analytical learning models and cohort outcomes to deliver personalized, cost-effective care.
Prosoma is a digital health technology innovator founded in 2018 with its registered seat in Poland and operational presence in Amsterdam, the Netherlands. The company develops digital therapeutics designed to reinvent healthcare and redefine patient mental well-being.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.